Navigation Links
Doctors Report High Survival Rates for Hodgkin's Disease
Date:11/7/2007

Treatments are improving, and researchers even talk of a cure

WEDNESDAY, Nov. 7 (HealthDay News) -- Here's an example of progress in cancer treatment: a trial that produced long-term survival rates better than 90 percent and that is described as outmoded because it's been replaced by treatments that get even better results with fewer side effects.

The cancer is Hodgkin's disease, a type of lymphoma, or cancer of lymph tissue found in the lymph nodes, spleen, liver and bone marrow. And the new findings come from a European group led by French physicians. They are reporting five-year, disease-free survival as high as 98 percent for patients with the most favorable prognosis and in the mid-80s or better for those who showed up with a worse outlook.

The results are published in the Nov. 8 issue of the New England Journal of Medicine.

It's not an easy paper for a layman to read, because it is full of acronyms for the combination chemotherapy that was used (MOPP-ABV) and different cycles of radiation therapy. The study conclusion is that this "should be the standard treatment for Hodgkin's disease with favorable prognostic features."

But then there's the accompanying editorial by Dr. Volker Diehl of the University of Cologne, in Germany, which says that these results have been overtaken by time and better treatments.

MOPP-ABV now has been replaced by a different chemotherapy regimen, called ABVD, Diehl said, with even better survival rates. And research now is centered on such issues as possible reductions in radiation therapy, he said.

The standard procedure for people with early-stage Hodgkin's disease is to classify them as "higher" or "lower" risk on the basis of such things as age, symptoms and spread into lymph nodes, said Dr. Mitchell Smith, director of lymphoma service at the Fox Chase Cancer Center in Philadelphia.

About two-thirds of Hodgkin's cases are early stage. Those diagnosed in later stages get the same basic treatment, but more of it -- radiation plus cycles of ABVD chemotherapy. It has replaced MOPP-ABV because it causes fewer side effects, such as problems with sterility, Smith said.

"In a favorable group, you get close to 95 percent five-year survival with the right treatment," Smith said. "In the unfavorable group, it is close to 80 percent. Very few people relapse after five years."

The new approach is close monitoring of patients' condition during treatment to determine how much radiation therapy is needed -- not so much the amount but how large an area of the body should be irradiated. There is a hope that chemotherapy alone can cure some patients, Diehl's editorial said.

"Dr. Diehl and the German group are doing among the best Hodgkin work now," said Dr. Bart Kamen, chief medical officer of the Leukemia and Lymphoma Society. "It is an editorial right on the mark as far as I am concerned."

And Smith does not shy away from saying "cure," a word long shunned in cancer treatment. With a 95 percent disease-free rate after five years and few relapses after that, why not use the word when dealing with Hodgkin's disease, he asked.

"Most people will be comfortable with cure in five to 10 years," Smith said.

More information

You can learn more about Hodgkin's disease from the U.S. National Library of Medicine.



SOURCES: Mitchell Smith, M.D., director, lymphoma service, Fox Chase Cancer Center, Philadelphia; Bart Kamen, M.D., chief medical officer, Leukemia and Lymphoma Society, White Plains, N.Y.; Nov. 8, 2007, New England Journal of Medicine


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. UK junior doctors gaining less experience of common procedures
2. Doctors Often Miss High Blood Pressure in Kids
3. One-fourth of HIV patients believe their doctors stigmatize them
4. Annual flu shot cuts need for doctors visits, hospitalization among children
5. Teens need to see their doctors more often
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
8. South Texas Doctors Report More Severe Cases of Community Staph Super Bug Hospitalizing Children
9. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
10. Doctors Debate Drugs vs. Surgery for Angina
11. UCI Medical Affiliates Inc. Opens a New Doctors Care Center in Anderson
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Doctors Report High Survival Rates for Hodgkin's Disease
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
Breaking Medicine Technology: